Abstract
The potent immunosuppressive action of rapamycin has been described in many different mouse models of transplantation. In these models, rapamycin prevent or delay allograft rejection. In several models, rapamycin allowed mixed donor–recipient hematopoietic chimerism to develop facilitating tolerance induction. In our own experience, we observed that rapamycin synergized with CD8+ T cell depletion and coreceptor/costimulation blockade to induce long-term survival of Balb/C to C57Bl/6 heterotopic limb allograft. Herein, we describe immunosuppression cocktails containing rapamycin and methods to evaluate several read outs associated with tolerance induction such as mixed donor–recipient hematopoietic chimerism and in vitro or in vivo recipient alloreactivity.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Thomson, A. W., H. R. Turnquist, and G. Raimondi. 2009. Immunoregulatory functions of mTOR inhibition. Nat. Rev. Immunol. 9: 324–337.
Weichhart, T., and M. D. Saemann. 2009. The multiple facets of mTOR in immunity. Trends Immunol. 30: 218–226.
Raimondi, G., T. L. Sumpter, B. M. Matta, M. Pillai, N. Corbitt, Y. Vodovotz, Z. Wang, and A. W. Thomson. 2010. Mammalian target of rapamycin inhibition and alloantigen-specific regulatory T cells synergize to promote long-term graft survival in immunocompetent recipients. J. Immunol. 184: 624–636.
Pilat, N., and T. Wekerle. 2010. Mechanistic and therapeutic role of regulatory T cells in tolerance through mixed chimerism. Curr. Opin. Organ Transplant.
Lim, D. G., S. K. Koo, Y. H. Park, Y. Kim, H. M. Kim, C. S. Park, S. C. Kim, and D. J. Han. 2010. Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4 + CD25 + Foxp3+ regulatory T cells in allotransplantation. Transplantation 89: 928–936.
Daniel, C., K. Wennhold, H. J. Kim, and B. H. von. 2010. Enhancement of antigen-specific Treg vaccination in vivo. Proc. Natl. Acad. Sci. U. S. A 107: 16246–16251.
Metzler, B., P. Gfeller, G. Wieczorek, and A. Katopodis. 2008. Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin. Transpl. Immunol. 20: 106–112.
Li, Z., F. S. Benghiat, L. M. Charbonnier, C. Kubjak, M. N. Rivas, S. P. Cobbold, H. Waldmann, W.De, V, M. Petein, F. Schuind, M. Goldman, and M. A. Le. 2008. CD8+ T-Cell depletion and rapamycin synergize with combined coreceptor/stimulation blockade to induce robust limb allograft tolerance in mice. Am. J. Transplant. 8: 2527–2536.
Pilat, N., U. Baranyi, C. Klaus, E. Jaeckel, N. Mpofu, F. Wrba, D. Golshayan, F. Muehlbacher, and T. Wekerle. 2010. Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am. J. Transplant. 10: 751–762.
Blaha, P., S. Bigenzahn, Z. Koporc, M. Schmid, F. Langer, E. Selzer, H. Bergmeister, F. Wrba, J. Kurtz, C. Kiss, E. Roth, F. Muehlbacher, M. Sykes, and T. Wekerle. 2003. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 101: 2886–2893.
McFarland, H. I., and A. S. Rosenberg. 2009. Skin allograft rejection. Curr. Protoc. Immunol. Chapter 4: Unit.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Charbonnier, LM., Le Moine, A. (2012). Rapamycin as Immunosuppressant in Murine Transplantation Model. In: Weichhart, T. (eds) mTOR. Methods in Molecular Biology, vol 821. Humana Press. https://doi.org/10.1007/978-1-61779-430-8_28
Download citation
DOI: https://doi.org/10.1007/978-1-61779-430-8_28
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-429-2
Online ISBN: 978-1-61779-430-8
eBook Packages: Springer Protocols